{"altmetric_id":3450440,"counts":{"readers":{"mendeley":66,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":2,"unique_users":["9038897997","1418785991701301"],"posts_count":2},"news":{"unique_users_count":1,"unique_users":["pharmastar_italy"],"posts_count":1},"total":{"posts_count":25},"twitter":{"unique_users_count":20,"unique_users":["Cancer_Cell","ElementoLab","SullivanJamesF","NatRevClinOncol","ParvathaneniNK","AZBioMarkers","duggiewest","BairdAM","nayakprakash","andybreathe","Tony_Calles","ASCO","gtjaden","superscience71","joseasanchezf","TrueDiagnostics","pedrazosfroilan","RielyMD","mlazqui","mtmdphd"],"posts_count":20},"weibo":{"unique_users_count":1,"unique_users":["\u67e5\u5c14\u65af\u6c83\u601d\u4e2d\u56fd\u533b\u5b66\u5fae\u535a"],"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:14818761"],"posts_count":1}},"selected_quotes":["Crizotinib highly active in lung cancer in pts with a ROS1 rearrangement, suggesting pts should be tested for ROS1","Retrospective European confirmation of clinical benefit of crizotinib in ROS1 fusion lung cancer J Clin Oncol @ASCO.","Crizotinib for Advanced Lung Adenocarcinoma a ROS1 Rearrangement #JCO #LCSM","overview of ROS1 lung cancer"],"citation":{"abstract":"Approximately 1% of lung adenocarcinomas are driven by oncogenic ROS1 rearrangement. Crizotinib is a potent inhibitor of both ROS1 and ALK kinase domains.","abstract_source":"pubmed","altmetric_jid":"4f6fa5e93cf058f610005a18","authors":["Julien Mazi\u00e8res","G\u00e9rard Zalcman","Lucio Crin\u00f2","Pamela Biondani","Fabrice Barlesi","Thomas Filleron","Anne-Marie C. Dingemans","Herv\u00e9 L\u00e9na","Isabelle Monnet","Sacha I. Rothschild","Federico Cappuzzo","Benjamin Besse","Luc Thiberville","Damien Rouvi\u00e8re","Rafal Dziadziuszko","Egbert F. Smit","Jurgen Wolf","Christian Spirig","Nicolas Pecuchet","Frauke Leenders","Johannes M. Heuckmann","Joachim Diebold","Julie D. Milia","Roman K. Thomas","Oliver Gautschi"],"doi":"10.1200\/jco.2014.58.3302","first_seen_on":"2015-02-10T12:38:13+00:00","issns":["1527-7755"],"journal":"Journal of Clinical Oncology","last_mentioned_on":1444426845,"links":["http:\/\/jco.ascopubs.org\/content\/early\/2015\/02\/03\/JCO.2014.58.3302?cmpid=jco_pap_9Feb2015","http:\/\/jco.ascopubs.org\/content\/early\/2015\/02\/03\/JCO.2014.58.3302.short?rss=1","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25667280?dopt=Abstract","http:\/\/m.jco.ascopubs.org\/content\/early\/2015\/02\/03\/JCO.2014.58.3302.short?rss=1","http:\/\/jco.ascopubs.org\/content\/early\/2015\/02\/03\/JCO.2014.58.3302.abstract#.VOdGkeNIxy0.twitter","http:\/\/jco.ascopubs.org\/content\/early\/2015\/02\/03\/JCO.2014.58.3302.abstract","http:\/\/jco.ascopubs.org\/content\/early\/2015\/02\/03\/JCO.2014.58.3302.abstract?sid=a48756f2-375b-487f-ab2f-c2cf6e3135b3","http:\/\/dx.doi.org\/10.1200\/JCO.2014.58.3302","http:\/\/jco.ascopubs.org\/content\/33\/9\/992.short?rss=1","http:\/\/jco.ascopubs.org\/content\/33\/9\/992.full.pdf+html?frame=sidebar#.VRFswPp-okk.twitter","http:\/\/jco.ascopubs.org\/content\/33\/9\/992.full","http:\/\/jco.ascopubs.org\/content\/33\/9\/992?cmpid=jco_etoc_20March2015","http:\/\/jco.ascopubs.org\/content\/33\/9\/992.short?rss=1&ssource=mfr","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25667280"],"pdf_url":"http:\/\/jco.ascopubs.org\/content\/early\/2015\/02\/03\/JCO.2014.58.3302.full.pdf","pmid":"25667280","pubdate":"2015-02-09T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/crizotinib-therapy-advanced-lung-adenocarcinoma-ros1-rearrangement-results-euros1-cohort"},"altmetric_score":{"score":26,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":26},"context_for_score":{"all":{"total_number_of_other_articles":6243250,"mean":5.9562086090129,"rank":219090,"this_scored_higher_than_pct":96,"this_scored_higher_than":6023303,"rank_type":"exact","sample_size":6243250,"percentile":96},"similar_age_3m":{"total_number_of_other_articles":192782,"mean":8.7604873198086,"rank":11134,"this_scored_higher_than_pct":94,"this_scored_higher_than":181614,"rank_type":"exact","sample_size":192782,"percentile":94},"this_journal":{"total_number_of_other_articles":6668,"mean":12.209313034348,"rank":712,"this_scored_higher_than_pct":89,"this_scored_higher_than":5955,"rank_type":"exact","sample_size":6668,"percentile":89},"similar_age_this_journal_3m":{"total_number_of_other_articles":205,"mean":24.970833333333,"rank":66,"this_scored_higher_than_pct":67,"this_scored_higher_than":139,"rank_type":"exact","sample_size":205,"percentile":67}}},"demographics":{"poster_types":{"member_of_the_public":12,"researcher":4,"practitioner":2,"science_communicator":2},"users":{"twitter":{"cohorts":{"Members of the public":9,"Science communicators (journalists, bloggers, editors)":2,"Scientists":5,"Practitioners (doctors, other healthcare professionals)":4}},"mendeley":{"by_status":{"Unspecified":4,"Professor > Associate Professor":5,"Researcher":16,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":7,"Student  > Postgraduate":4,"Student  > Master":5,"Other":13,"Student  > Bachelor":6,"Lecturer":1,"Professor":2},"by_discipline":{"Medicine and Dentistry":39,"Chemistry":1,"Agricultural and Biological Sciences":8,"Nursing and Health Professions":1,"Business, Management and Accounting":1,"Biochemistry, Genetics and Molecular Biology":5,"Unspecified":10,"Environmental Science":1}}},"geo":{"twitter":{"US":7,"GB":2,"ES":2},"mendeley":{"JP":1,"CN":1,"BR":1,"GB":1,"CH":1}}},"posts":{"wikipedia":[{"title":"ROS1","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=684958565#altmetric_citation_40f6eec6-2dd7-4e3d-b004-3127946ef5c2","license":"public","citation_ids":[3450440],"posted_on":"2015-10-09T21:40:45+00:00","summary":"Proto-oncogene tyrosine-protein kinase ROS is an enzyme that in humans is encoded by the ROS1 gene.","page_url":"http:\/\/en.wikipedia.org\/?curid=14818761","wiki_lang":"en","author":{"name":"209.117.92.51","url":"http:\/\/en.wikipedia.org\/wiki\/Special:Contributions\/209.117.92.51"}}],"twitter":[{"url":"https:\/\/twitter.com\/Cancer_Cell\/status\/565121064254984192","license":"datasift","citation_ids":[3450440],"posted_on":"2015-02-10T12:12:15+00:00","author":{"name":"Cancer Cell","url":"http:\/\/www.cell.com\/cancer-cell","image":"https:\/\/pbs.twimg.com\/profile_images\/2218750550\/cctwitLogo_128_normal.jpg","description":"Cancer Cell provides a high-profile forum for showcasing advances in cancer research, with a strong emphasis on translational research.","id_on_source":"Cancer_Cell","tweeter_id":"580269594","geo":{"lt":42.3751,"ln":-71.10561,"country":"US"},"followers":11031},"tweet_id":"565121064254984192"},{"url":"https:\/\/twitter.com\/ElementoLab\/status\/565123810106413056","license":"datasift","rt":["Cancer_Cell"],"citation_ids":[3450440],"posted_on":"2015-02-10T12:23:10+00:00","author":{"name":"Olivier Elemento","url":"http:\/\/physiology.med.cornell.edu\/faculty\/elemento\/lab\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1793980317\/OE-outside_normal.jpg","description":"Director, Englander Institute for Precision Medicine & Associate Director, Institute for Computational Biomedicine @weillcornell","id_on_source":"ElementoLab","tweeter_id":"464159257","geo":{"lt":40.71427,"ln":-74.00597,"country":"US"},"followers":2417},"tweet_id":"565123810106413056"},{"url":"https:\/\/twitter.com\/SullivanJamesF\/status\/565142919737126912","license":"datasift","rt":["Cancer_Cell"],"citation_ids":[3450440],"posted_on":"2015-02-10T13:39:06+00:00","author":{"name":"Jim Sullivan","image":"https:\/\/pbs.twimg.com\/profile_images\/3371921615\/3eef229b8cf9c3078780fa393a251518_normal.jpeg","description":"Life Sciences business professional","id_on_source":"SullivanJamesF","tweeter_id":"915498402","geo":{"lt":null,"ln":null},"followers":55},"tweet_id":"565142919737126912"},{"url":"https:\/\/twitter.com\/NatRevClinOncol\/status\/565242830210478082","license":"datasift","citation_ids":[3450440],"posted_on":"2015-02-10T20:16:07+00:00","author":{"name":"NatureRevClinOncol","url":"http:\/\/www.nature.com\/nrclinonc\/index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/1587954262\/nrclinonc_Twitter_logo_normal.jpg","description":"The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.","id_on_source":"NatRevClinOncol","tweeter_id":"347276297","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":10481},"tweet_id":"565242830210478082"},{"url":"https:\/\/twitter.com\/ParvathaneniNK\/status\/565249127328776193","license":"datasift","rt":["NatRevClinOncol"],"citation_ids":[3450440],"posted_on":"2015-02-10T20:41:08+00:00","author":{"name":"Nanda Parvathaneni","image":"https:\/\/pbs.twimg.com\/profile_images\/730824733772648449\/Pjd2LcYO_normal.jpg","id_on_source":"ParvathaneniNK","tweeter_id":"1660690400","geo":{"lt":null,"ln":null},"followers":39},"tweet_id":"565249127328776193"},{"url":"https:\/\/twitter.com\/AZBioMarkers\/status\/565250336701435904","license":"datasift","rt":["Cancer_Cell"],"citation_ids":[3450440],"posted_on":"2015-02-10T20:45:56+00:00","author":{"name":"Eric Thompson, Ph.D.","url":"http:\/\/www.linkedin.com\/in\/ericthompsonbiomarkers\/","image":"https:\/\/pbs.twimg.com\/profile_images\/3783047477\/95b47756fb1d2bf72cdaa028d9a50497_normal.jpeg","description":"Precision medicine translational pharmacologist and cancer biologist, utilizing evidence based medicine to move biomarkers into the clinic.","id_on_source":"AZBioMarkers","tweeter_id":"1499192467","geo":{"lt":34.5003,"ln":-111.50098,"country":"US"},"followers":185},"tweet_id":"565250336701435904"},{"url":"https:\/\/twitter.com\/duggiewest\/status\/565250712385630210","license":"datasift","rt":["NatRevClinOncol"],"citation_ids":[3450440],"posted_on":"2015-02-10T20:47:26+00:00","author":{"name":"doug west","url":"http:\/\/www.ctsnet.org\/home\/dwest","image":"https:\/\/pbs.twimg.com\/profile_images\/807192110885642240\/224DflTd_normal.jpg","description":"#Thoracic surgeon in Bristol England. Society for Cardiothoracic Surgery thoracic audit lead. Tweeting personal interests only.","id_on_source":"duggiewest","tweeter_id":"29624902","geo":{"lt":51.45523,"ln":-2.59665,"country":"GB"},"followers":537},"tweet_id":"565250712385630210"},{"url":"https:\/\/twitter.com\/BairdAM\/status\/565256223894036482","license":"datasift","rt":["NatRevClinOncol"],"citation_ids":[3450440],"posted_on":"2015-02-10T21:09:20+00:00","author":{"name":"Anne-Marie Baird","url":"https:\/\/au.linkedin.com\/in\/bairdam","image":"https:\/\/pbs.twimg.com\/profile_images\/808324573812899840\/KEaq2i5J_normal.jpg","description":"Cancer Researcher (Lung, Mesothelioma, Prostate); Patient Advocate; IASLC Communications & Fellowship committee; Visiting fellow: QUT & TCD; #NoStigma #LCSM","id_on_source":"BairdAM","tweeter_id":"912929083","geo":{"lt":null,"ln":null},"followers":1891},"tweet_id":"565256223894036482"},{"url":"https:\/\/twitter.com\/nayakprakash\/status\/565317060579045376","license":"datasift","rt":["NatRevClinOncol"],"citation_ids":[3450440],"posted_on":"2015-02-11T01:11:04+00:00","author":{"name":"Prakash Nayak","image":"https:\/\/pbs.twimg.com\/profile_images\/823933929971326976\/QcJiwVRP_normal.jpg","description":"Orthopedic Oncologist | Sarcoma service\nAssistant Professor | Surgical Oncology |\nTata Memorial Hospital, Mumbai |\n\nRetweets are not endorsements","id_on_source":"nayakprakash","tweeter_id":"30828728","geo":{"lt":null,"ln":null},"followers":202},"tweet_id":"565317060579045376"},{"url":"https:\/\/twitter.com\/andybreathe\/status\/566113792409755648","license":"datasift","citation_ids":[3450440],"posted_on":"2015-02-13T05:57:00+00:00","author":{"name":"Andreas-Cl. Hoffmann","url":"http:\/\/www.more-oncology.de\/","image":"https:\/\/pbs.twimg.com\/profile_images\/827830830995234817\/Bbly2akM_normal.jpg","description":"Hematologist, Medical Oncologist, Cancer Researcher, Follow-up Care After Cancer Treatment, Oncology Rehabilitation, tweets and opinions expressed are my own","id_on_source":"andybreathe","tweeter_id":"220780239","geo":{"lt":null,"ln":null},"followers":421},"tweet_id":"566113792409755648"},{"url":"https:\/\/twitter.com\/Tony_Calles\/status\/568390639295070208","license":"datasift","citation_ids":[3450440],"posted_on":"2015-02-19T12:44:23+00:00","author":{"name":"Dr. Antonio Calles","url":"http:\/\/www.linkedin.com\/profile\/view?id=161163018&trk=nav_responsive_tab_profile","image":"https:\/\/pbs.twimg.com\/profile_images\/725067602297556992\/2Vb_n1K8_normal.jpg","description":"Onc\u00f3logo M\u00e9dico. Trato y empodero pacientes con c\u00e1ncer de pulm\u00f3n. Hospital General Universitario Gregorio Mara\u00f1\u00f3n. Power to the patients. #endlungcancer #lcsm","id_on_source":"Tony_Calles","tweeter_id":"2155543177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1474},"tweet_id":"568390639295070208"},{"url":"https:\/\/twitter.com\/ASCO\/status\/568779879556255744","license":"datasift","citation_ids":[3450440],"posted_on":"2015-02-20T14:31:05+00:00","author":{"name":"ASCO","url":"http:\/\/www.asco.org","image":"https:\/\/pbs.twimg.com\/profile_images\/463779450388090880\/UsaXUpTx_normal.png","description":"ASCO is the American Society of Clinical Oncology. Making a world of difference in cancer care.","id_on_source":"ASCO","tweeter_id":"20187065","geo":{"lt":38.80484,"ln":-77.04692,"country":"US"},"followers":68867},"tweet_id":"568779879556255744"},{"url":"https:\/\/twitter.com\/gtjaden\/status\/568781772764405760","license":"datasift","citation_ids":[3450440],"posted_on":"2015-02-20T14:38:36+00:00","author":{"name":"Gabrielle Tjaden","image":"https:\/\/pbs.twimg.com\/profile_images\/512634332096106496\/Wlc4sEYG_normal.jpeg","id_on_source":"gtjaden","tweeter_id":"30541964","followers":40},"tweet_id":"568781772764405760"},{"url":"https:\/\/twitter.com\/superscience71\/status\/568790694644621312","license":"datasift","rt":["ASCO"],"citation_ids":[3450440],"posted_on":"2015-02-20T15:14:03+00:00","author":{"name":"Sean Gregory","image":"https:\/\/pbs.twimg.com\/profile_images\/772447269769609216\/-a_sl0eO_normal.jpg","description":"Do something inspirational today.","id_on_source":"superscience71","tweeter_id":"383566613","geo":{"lt":null,"ln":null},"followers":40},"tweet_id":"568790694644621312"},{"url":"https:\/\/twitter.com\/joseasanchezf\/status\/568811424811769857","license":"datasift","rt":["ASCO"],"citation_ids":[3450440],"posted_on":"2015-02-20T16:36:26+00:00","author":{"name":"Jos\u00e9 Alberto S\u00e1nchez","image":"https:\/\/pbs.twimg.com\/profile_images\/547125550834524160\/u5n2VE0j_normal.jpeg","id_on_source":"joseasanchezf","tweeter_id":"1846601563","geo":{"lt":null,"ln":null},"followers":17},"tweet_id":"568811424811769857"},{"url":"https:\/\/twitter.com\/TrueDiagnostics\/status\/578329350933725185","license":"datasift","citation_ids":[3450440],"posted_on":"2015-03-18T22:57:16+00:00","author":{"name":"Jerry Lee","url":"http:\/\/www.truediag.com","image":"https:\/\/pbs.twimg.com\/profile_images\/567483990097936384\/6uKJglvi_normal.jpeg","description":"We specialize in providing quick & simple quantitative test systems designed for point-of-care monitoring. Test results in minutes not days..","id_on_source":"TrueDiagnostics","tweeter_id":"317232537","geo":{"lt":32.71533,"ln":-117.15726,"country":"US"},"followers":374},"tweet_id":"578329350933725185"},{"url":"https:\/\/twitter.com\/pedrazosfroilan\/status\/580367289528254464","license":"datasift","citation_ids":[3450440],"posted_on":"2015-03-24T13:55:19+00:00","author":{"name":"Paco Olba","image":"https:\/\/pbs.twimg.com\/profile_images\/704348675041062912\/PnyywHGW_normal.jpg","description":"Asturiano, amante de sus ra\u00edces","id_on_source":"pedrazosfroilan","tweeter_id":"2301326171","geo":{"lt":null,"ln":null},"followers":124},"tweet_id":"580367289528254464"},{"url":"https:\/\/twitter.com\/RielyMD\/status\/580820780734398464","license":"datasift","citation_ids":[3446912,3450440],"posted_on":"2015-03-25T19:57:19+00:00","author":{"name":"Gregory Riely","url":"http:\/\/www.mskcc.org\/cancer-care\/doctor\/gregory-riely","image":"https:\/\/pbs.twimg.com\/profile_images\/417048782061072384\/_0a_yv3o_normal.jpeg","description":"Medical Oncologist at Memorial Sloan Kettering Cancer Center.  Clinical focus on lung and thymic malignancies","id_on_source":"RielyMD","tweeter_id":"301164011","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":1717},"tweet_id":"580820780734398464"},{"url":"https:\/\/twitter.com\/mlazqui\/status\/584662647108435969","license":"datasift","citation_ids":[3450440],"posted_on":"2015-04-05T10:23:32+00:00","author":{"name":"Mart\u00edn L\u00e1zaro","url":"http:\/\/www.novedadesenoncologia.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000653691864\/11d6fb0c77217bfce2c907aa9b0f2ee5_normal.jpeg","description":"Medical oncologist. Lung and genitourinary cancer.","id_on_source":"mlazqui","tweeter_id":"196132848","geo":{"lt":42.23282,"ln":-8.72264,"country":"ES"},"followers":1691},"tweet_id":"584662647108435969"},{"url":"https:\/\/twitter.com\/mtmdphd\/status\/568830434567712768","license":"datasift","citation_ids":[3450440],"posted_on":"2015-02-20T17:51:58+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15360},"tweet_id":"568830434567712768"}],"news":[{"title":"Ca al polmone, crizotinib molto efficace nel tumore avanzato ROS-1-positivo [OncoEmato]","url":"http:\/\/www.pharmastar.it\/index.html?cat=22&id=17652","license":"public","citation_ids":[3450440],"posted_on":"2015-03-04T00:00:00+00:00","summary":"Crizotinib si \u00e8 dimostrato sorprendentemente efficace contro l'adenocarcinoma del polmone non a piccole cellule in stadio 4 refrattario e con riarrangiamenti dell'oncogene C-ros 1 (ROS1) in un piccolo studio di coorte retrospettivo, pubblicato di recente s","author":{"name":"Pharmastar Italy","url":"http:\/\/pharmastar.it\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/289\/normal\/Screen_Shot_2014-11-27_at_11.59.12.png?1417089569"}}],"facebook":[{"url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10152776918047998&id=9038897997","license":"public","citation_ids":[3450440],"posted_on":"2015-02-20T16:10:00+00:00","summary":"\"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort\" JCO Original Report by Drs. Julien Mazi\u00e8res, G\u00e9rard Zalcman, Lucio Crin\u00f2, et al.  http:\/\/bit.ly\/199EO3n","author":{"name":"American Society of Clinical Oncology","url":"https:\/\/www.facebook.com\/9038897997","facebook_wall_name":"American Society of Clinical Oncology","image":"https:\/\/graph.facebook.com\/9038897997\/picture","id_on_source":"9038897997"}},{"title":"JCO : Journal of Clinical Oncology","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1561142787465620&id=1418785991701301","license":"public","citation_ids":[3450440],"posted_on":"2015-02-19T12:44:28+00:00","summary":"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort Via@asco\nhttp:\/\/t.co\/OtOQOknANH","author":{"name":"Doctor Antonio Calles","url":"https:\/\/www.facebook.com\/1418785991701301","facebook_wall_name":"Doctor Antonio Calles","image":"https:\/\/graph.facebook.com\/1418785991701301\/picture","id_on_source":"1418785991701301"}}],"weibo":[{"url":"http:\/\/weibo.com\/2527977815\/CajBqy2lS","license":"public","citation_ids":[3450440],"posted_on":"2015-03-26T02:11:50+00:00","summary":"# ASCO \u7814\u7a76\u8fdb\u5c55#\u300a\u4e34\u5e8a\u80bf\u7624\u5b66\u6742\u5fd7\u300b\uff1a \u514b\u5511\u66ff\u5c3c\uff08Crizotinib\uff09\u6cbb\u7597ROS1\u91cd\u6392\u60a3\u8005\u6709\u663e\u8457\u7597\u6548\uff0c\u63d0\u793a\u80ba\u817a\u764c\u60a3\u8005\u5e94\u68c0\u6d4bROS1. http:\/\/t.cn\/RALGkMB","author":{"name":"\u67e5\u5c14\u65af\u6c83\u601d\u4e2d\u56fd\u533b\u5b66\u5fae\u535a","image":"http:\/\/tp4.sinaimg.cn\/2527977815\/50\/5619329315\/1","description":"\u67e5\u5c14\u65af\u6c83\u601d\u96c6\u56e2\u662f\u4e16\u754c\u9886\u5148\u7684\u51fa\u7248\u3001\u5370\u5237\u670d\u52a1\u63d0\u4f9b\u5546\u548c\u7248\u6743\u4ee3\u7406\u673a\u6784\u3002\u67e5\u5c14\u65af\u96c6\u56e2\u6210\u7acb\u4e8e1928\u5e74\uff0c\u603b\u90e8\u4f4d\u4e8e\u82f1\u56fd\uff0c\u5728\u7f8e\u56fd\u548c\u4e2d\u56fd\u8bbe\u6709\u5206\u516c\u53f8\u3002\u67e5\u5c14\u65af\u6c83\u601d\u2022\u4e2d\u56fd1999\u5e74\u6210\u7acb\u4e8e\u5317\u4eac\uff0c\u662f\u67e5\u5c14\u65af\u6c83\u601d\u96c6\u56e2\u5728\u4e2d\u56fd\u7684\u5168\u8d44\u5b50\u516c\u53f8\u3002\u6210\u7acb\u4e4b\u521d\uff0c\u4e3b\u8981\u662f\u4e3a\u82f1\u56fd\u603b\u516c\u53f8\u63d0\u4f9b\u8f85\u52a9\u670d\u52a1\u3002\u7ecf\u8fc7\u5341\u5e74\u7684\u53d1\u5c55\uff0c\u67e5\u5c14\u65af\u6c83\u601d\u2022\u4e2d\u56fd\u76ee\u524d\u5171\u6709\u5458\u5de5\u8fd1200\u540d\uff0c\u5728\u5317\u4eac\u548c\u5eca\u574a\u5206\u522b\u8bbe\u6709\u5206\u516c\u53f8\uff0c\u4e1a\u52a1\u8303\u56f4\u4ece\u8bed\u8a00\u7f16\u8f91\u6da6\u8272\u3001\u5185\u5bb9\u7ba1\u7406\u3001\u6392\u7248\u3001\u6570\u5b57\u5316\u51fa\u7248\u5230\u53d1\u884c\u3001\u8ba2\u9605\u4e0e\u7248\u6743\u7ba1\u7406\u7b49\u5168\u65b9\u4f4d\u670d\u52a1\u3002\u5ba2\u6237\u6db5\u76d6\u56fd\u9645\u8457\u540d\u7684\u79d1\u6280\u51fa\u7248\u793e\u3001\u533b\u5b66\u51fa\u7248\u793e\u3001\u5b66\u534f\u4f1a\u548c\u7814\u7a76\u6240\u4ee5\u53ca\u653f\u5e9c\u90e8\u95e8\u3001\u5927\u5b66\u548c\u975e\u76c8\u5229\u7ec4\u7ec7\u3002","id_on_source":"2527977815","followers":878}}]}}